<div><strong>When my daughter Mila was 6-years-old, she was given a death sentence.</strong>
</div>
<div><br />
</div>
<div>But we decided to fight for her life, together with supporters from all over the world. <strong>Then something amazing happened.</strong>
</div>
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575167474932583_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575167474932583_r.jpeg" width="100%" />
<div><br />
</div>
<div><br />
</div>
<div>Mila could have been your child. <strong>She ran around playgrounds, ate ice cream by the pool and sang the ABCs like every other kid.</strong> She learned to ski and climb rocks.
</div>
<div><br />
</div>
<div><strong>But something changed.</strong>
</div>
<div><br />
</div>
<div>Mila started tripping and falling and pulling her toys in close to her face. On her sixth birthday, she lost her vision. She had her first seizure. And said "mommy" for the last time. She was<strong> finally diagnosed with a 100% fatal condition, Batten disease</strong>. My heart stopped. My body went limp.
</div>
<div><br />
</div>
<div><strong>No cure. No treatments. No hope.</strong>
</div>
<div><br />
</div>
<div>After a one-year race against time, <strong>Mila was given an unprecedented second chance at life. </strong>
</div>
<div><br />
</div>
<div><strong>She became the first person in the world to receive a drug tailored to just one person - called "milasen". </strong>
</div>
<div><br />
</div>
<div>Suddenly, her rapid downward spiral seemed to come to a halt. Mila's symptom progression slowed, her quality of life improved. But ultimately we were not in time for Mila, and her big beautiful spirit flew away when she was just ten years old.
</div>
<div><br />
</div>
<div>I can't help but ask myself <strong>"What would Mila's life look like if she was treated just a few years earlier or perhaps at birth?"</strong>
</div>
<div><br />
</div>
<div>Together, we made milasen possible. Her story is changing medicine around the world. Now, <strong>other children like Mila deserve the same chance before their time runs out. </strong>
</div>
<div><br />
</div>
<div>We are working to create an entirely new treatment path for individualized medicines that Mila pioneered to <strong>help solve the global health crisis </strong>of millions of sick and dying children with genetic diseases. 
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Please HELP US move from Mila to Millions, giving children a chance at life!</strong>
</div>
<div><strong>_______________________________________</strong>
</div>
<div><br />
</div>
<div><strong>YOU can help!</strong>
</div>
<div><br />
</div>
<div><strong>1) GIVE </strong>whatever you can. No donation is too small (tax-deductible)
</div>
<div><strong>2) SHARE </strong>on social media (#MilaToMillions)
</div>
<div><strong>3) EMAIL </strong>this page - gofundme.com/savingmoremilas - to your family + friends. 
</div>
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575298287191628_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575298287191628_r.jpeg" width="100%" />
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575168393862568_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575168393862568_r.jpeg" width="100%" />
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575168503432699_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575168503432699_r.jpeg" width="100%" />
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575168372233289_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575168372233289_r.jpeg" width="100%" />
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575168651169055_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575168651169055_r.jpeg" width="100%" />
<div><br />
</div>
<div><strong>WHERE YOUR MONEY IS GOING</strong>
</div>
<div>Mila's Miracle Foundation, Inc. is a 501(c)(3) nonprofit organization. Our mission is to find and fund treatments for children with devastating neurological diseases, like Batten. Saving lives is expensive. Mila and other children like her deserve a second chance that recent genetic breakthroughs now offer. We CAN save children's lives together!
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Milasen is changing the landscape of drug development.</strong> The work led by Dr. Yu and Boston Children's Hospital and funded by Mila's Miracle Foundation was first published in the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1813279?query=recirc_curatedRelated_article+https%25253A%25252F%25252Fdrive.google.com%25252Fopen%25253Fid%25253D1J2hJY55iZiT3y96JWgYy0S4iXrT9_QTN" target="_blank" rel="noreferrer noopener">New England Journal of Medicine</a> accompanied by an <a href="https://www.nejm.org/doi/full/10.1056/NEJMe1911295" target="_blank" rel="noreferrer noopener">important editorial</a> written by Janet Woodcock and Peter Marks from the FDA. Since then, Mila's story has been featured in over <a href="https://www.milasmiracle.org/media" target="_blank" rel="noreferrer noopener">100 articles</a> in 28 countries - including <a href="https://www.nytimes.com/2019/10/09/health/mila-makovec-drug.html" target="_blank" rel="noreferrer noopener">The New York Times</a> , <a href="https://www.sciencemag.org/news/2019/10/drug-tailored-one-girl-brain-disease-paves-way-similar-customized-treatments" target="_blank" rel="noreferrer noopener">Science Magazine</a> , <a href="https://www.economist.com/britain/2023/11/22/the-worlds-first-pathway-for-individually-designed-drugs" target="_blank" rel="noreferrer noopener">The Economist</a> , <a href="https://www.statnews.com/2022/02/09/julia-vitarello-mila-rare-diseases-custom-drug-development/" target="_blank" rel="noreferrer noopener">STAT</a> , <a href="https://www.technologyreview.com/2019/10/09/102551/this-girls-dramatic-story-shows-hyper-personalized-medicine-is-possibleand-costly/" target="_blank" rel="noreferrer noopener">MIT Technology Review</a> , <a href="https://directorsblog.nih.gov/2019/10/23/one-little-girls-story-highlights-the-promise-of-precision-medicine/" target="_blank" rel="noreferrer noopener">NIH Director’s Blog</a> and the <a href="https://www.bbc.com/news/health-49959738" target="_blank" rel="noreferrer noopener">BBC</a> . 
</div>
<div><br />
</div>
<div><br />
</div><img alt="43767940_1575311670364973_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/43767940_1575311670364973_r.jpeg" width="100%" />
<div><br />
</div>

Anonymous

Bharath Srisailam

Thomas Lauzon

Winston Yan

Madonna Vitarello

Sarah Cottingham

rosalyn doggett

Saving More Milas

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Saving More Milas

Still $13,142 to go. Help us build momentum.